Eton Pharmaceuticals (ETON) EBT Margin (2019 - 2025)

Eton Pharmaceuticals has disclosed EBT Margin across 7 years of filings, most recently posting 6.64% for Q4 2025.

• EBT Margin for Q4 2025 came in at 6.64%, up 1103.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 7.07% (up 269.0% YoY), and the FY2025 annual result was 5.7%, up 406.0% from the prior year.
• EBT Margin came in at 6.64% for Q4 2025 at Eton Pharmaceuticals, up from 8.7% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 43.0% in Q1 2021 to a low of 786.32% in Q3 2021.
• The 5-year median for EBT Margin is 9.44% (2024), against an average of 66.05%.
• Peak annual rise in EBT Margin reached 2358427 bps in 2021, while the deepest fall reached 25621628 bps in 2021.
• Eton Pharmaceuticals' EBT Margin stood at 17.05% in 2021, then slumped by 37 bps to 10.73% in 2022, then plunged by 163 bps to 6.74% in 2023, then surged by 35 bps to 4.39% in 2024, then soared by 251 bps to 6.64% in 2025.
• The last three EBT Margin figures came in at 6.64% (Q4 2025), 8.7% (Q3 2025), and 13.31% (Q2 2025), per Business Quant data.